Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.
Kim HS, Choi WH, Kim BY, Kim SS, Lee SI, Kim SH, Choi SJ, Kim GT, Hur JW, Lee MS, Kim YS, Hong SJ. Kim HS, et al. Among authors: lee si, lee ms. J Int Med Res. 2020 Jun;48(6):300060520931323. doi: 10.1177/0300060520931323. J Int Med Res. 2020. PMID: 32589073 Free PMC article. Clinical Trial.
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study.
Park MC, Matsuno H, Kim J, Park SH, Lee SH, Park YB, Lee YJ, Lee SI, Park W, Sheen DH, Choe JY, Choi CB, Hong SJ, Suh CH, Lee SS, Cha HS, Yoo B, Hur JW, Kim GT, Yoo WH, Baek HJ, Shin K, Shim SC, Yang HI, Kim HA, Park KS, Choi IA, Lee J, Tomomitsu M, Shin S, Lee J, Song YW. Park MC, et al. Among authors: lee sh, lee si, lee j, lee yj, lee ss. Arthritis Res Ther. 2019 May 21;21(1):122. doi: 10.1186/s13075-019-1910-2. Arthritis Res Ther. 2019. PMID: 31113455 Free PMC article. Clinical Trial.
Response to comment on "Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception".
Suh YS, Cheon YH, Kim HO, Kim RB, Park KS, Kim SH, Lee SG, Park EK, Hur J, Lee SI. Suh YS, et al. Among authors: lee sg, lee si. Korean J Intern Med. 2018 Nov;33(6):1254. doi: 10.3904/kjim.2018.269. Epub 2018 Oct 30. Korean J Intern Med. 2018. PMID: 30396256 Free PMC article. No abstract available.
Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach.
Lee JW, Kang JH, Lee KE, Park DJ, Kang SW, Kwok SK, Kim SK, Choe JY, Kim HA, Sung YK, Shin K, Lee SI, Lee CH, Choi SJ, Lee SS. Lee JW, et al. Among authors: lee ch, lee si, lee ke, lee ss. Qual Life Res. 2018 Jan;27(1):105-113. doi: 10.1007/s11136-017-1689-z. Epub 2017 Aug 22. Qual Life Res. 2018. PMID: 28831690
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
Matsuno H, Kang YM, Okada M, Lee SI, Park SH, Sheen DH, Sato M, Hagino A, Lee J, Shin S, Song YW. Matsuno H, et al. Among authors: lee si, lee j. Clin Exp Rheumatol. 2022 May;40(5):1025-1033. doi: 10.55563/clinexprheumatol/cyudn8. Epub 2021 Jul 7. Clin Exp Rheumatol. 2022. PMID: 34251303 Clinical Trial.
2,378 results